An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer Pain
ConclusionFentanyl citrate patch tended to result in a higher serum fentanyl concentration in pre-school patients than in school-aged, adolescent, and adult patients who received the same dose. The patch provided adequate pain control, was well tolerated, and did not cause respiratory adverse events.Trial Registration NumberJPRN-JapicCTI-183909.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Actiq | Blood Transusion | Cancer | Cancer & Oncology | Cancer in Adolescents | Drugs & Pharmacology | Fentanyl | Japan Health | Pain | Pediatrics | Respiratory Medicine | Study